Prudential Financial’s Sagimet Biosciences SGMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$101K Buy
+10,195
New +$93.7K ﹤0.01% 2418
2024
Q2
– Sell
-44,755
Closed -$243K – 2775
2024
Q1
$243K Buy
+44,755
New +$321K ﹤0.01% 2411

Other funds holding SGMT

Prudential Financial's SGMT Position: Q3 2026 in Review

Prudential Financial opened a new position in Sagimet Biosciences (SGMT) in Q3 2026: 10,195 shares worth $101K. The stake represents ﹤0.01% of the portfolio and ranks #2418 among its holdings. This is a return to the name: Prudential Financial previously reported a position in SGMT as recently as Q1 2024.

Prudential Financial first reported a position in SGMT in Q1 2024 and has held it in 2 quarters since. The position peaked at $243K in Q1 2024. 153 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.

  • Prudential Financial held 10,195 shares of Sagimet Biosciences worth $101K as of Q3 2026.
  • Sagimet Biosciences was a new Prudential Financial position in Q3 2026.
  • Sagimet Biosciences made up ﹤0.01% of Prudential Financial's portfolio in Q3 2026, its #2418 holding.
  • Prudential Financial first reported a position in Sagimet Biosciences in Q1 2024 and has held it in 2 quarters since.
  • Prudential Financial's Sagimet Biosciences position peaked at $243K in Q1 2024.
  • 153 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.

Based on Prudential Financial's 13F filing for Q3 2026, filed 16 Nov 2026.